Literature DB >> 6801483

[Therapy of multiple sclerosis with immunoglobulin G].

U Rothfelder, I Neu, R Pelka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6801483

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN： 0341-3098


× No keyword cloud information.
  6 in total

Review 1.  Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.

Authors:  Ales Dudesek; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 2.  Basic principles of intravenous immunoglobulin (IVIg) treatment.

Authors:  Martin Stangel; Refik Pul
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 3.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

Review 4.  Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials.

Authors:  P S Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 5.  [Intravenous immunoglobulins in multiple sclerosis. An update].

Authors:  S Schwarz; H-M Meinck; B Storch-Hagenlocher
Journal:  Nervenarzt       Date:  2009-08       Impact factor: 1.214

Review 6.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.